RVMD
Revolution Medicines, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +17.6% ·
aandelenstroom -0.6% ·
netto nieuwe posities +10.0%
· formule
Fragmentatie van eigendom: meer houders, kleiner totaalbelang
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 2.20M | $451.04M | n/a | n/a |
| Q2 2026 | 147 | +17 | 106.54M | $18.58B | +25 | −9 |
| Q1 2026 | 134 | +17 | 103.45M | $9.43B | +22 | −6 |
| Q4 2025 | 116 | +1 | 107.70M | $8.12B | +3 | −1 |
| Q3 2025 | 20 | +3 | 68.96M | $3.10B | +3 | −1 |
| Q2 2025 | 15 | 0 | 63.88M | $2.26B | n/a | n/a |
| Q1 2025 | 12 | +2 | 32.32M | $1.05B | +2 | n/a |
| Q4 2024 | 10 | -1 | 33.19M | $1.34B | n/a | −1 |
| Q3 2024 | 10 | -1 | 26.28M | $1.08B | n/a | −1 |
| Q2 2024 | 11 | n/a | 28.23M | $999.53M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 15.66M | -0.6% | $731.47M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | Wellington Management ✦ | 9.81M | -4.3% | $458.29M | 0.1% | ▼ Trim | 6 | SEC ↗ ×9 |
| 3 | Fidelity (FMR) ✦ | 9.40M | +12.9% | $439.06M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 4 | BlackRock ✦ (passief) | 8.33M | -3.9% | $388.91M | 0.0% | ▼ Trim | 2 | SEC ↗ ×16 |
| 5 | State Street Global Advisors ✦ (passief) | 5.25M | +11.3% | $245.39M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | JPMorgan Chase ✦ | 5.00M | n/a | $233.34M | 0.0% | n/c | 1 | SEC ↗ ×16 |
| 7 | T. Rowe Price ✦ | 4.47M | -15.7% | $181.08M | 0.0% | ▼ Trim | 6 | SEC ↗ ×3 |
| 8 | Geode Capital Management ✦ (passief) | 3.15M | +5.1% | $146.93M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 1.43M | n/a | $67.00M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 10 | Citadel Advisors ✦ | 1.18M | -20.1% | $55.11M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 11 | D. E. Shaw & Co. ✦ | 2.27M | +7.2% | $38.37M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 12 | Adage Capital Partners ✦ | 1.24M | +38.4% | $34.82M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | Goldman Sachs Group ✦ | 738.03K | n/a | $34.47M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 14 | Millennium Management ✦ | 428.31K | -69.0% | $20.00M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Renaissance Technologies ✦ | 253.10K | +3.9% | $11.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Marshall Wace ✦ | 161.10K | +482.0% | $7.52M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Gotham Asset Management ✦ | 99.11K | Nieuw | $4.63M | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 70.29K | +368.1% | $3.24M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 19 | Two Sigma Investments ✦ | 9.11K | Nieuw | $425,297 | 0.0% | New | 1 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 7.30K | Nieuw | $341,143 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Gotham Asset Management | $4.63M | 0.0% |
| Two Sigma Investments | $425,297 | 0.0% |
| Fisher Asset Management | $341,143 | 0.0% |
Verlaten
| Norges Bank | $62.58M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 509 houders, 197.96M aandelen, $18.53B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 765 aand · $158,600
Officer · 3.12K aand · $625,885
Officer · 587 aand · $117,400
Director · 910 aand · $174,585
Director · 4.99K aand · $959,805
Director · 1.50K aand · $291,883
Director · 100 aand · $19,515
Director · 2.65K aand · $512,227
Officer · 1.76K aand · $347,402
Officer, Director · 13.78K aand · $2.75M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie